Se. Lipshultz et al., PREDICTIVE VALUE OF CARDIAC TROPONIN-T IN PEDIATRIC-PATIENTS AT RISK FOR MYOCARDIAL INJURY, Circulation, 96(8), 1997, pp. 2641-2648
Background Biochemical markers have not been routinely used in childre
n at risk for myocardial damage. Yet, because of somatic growth and th
e duration of survival, a low level of myocardial damage may ultimatel
y be of more consequence in children than in adults. Methods and Resul
ts We investigated the utility of cardiac troponin T (cTnT) blood leve
ls (CARDIAC T ELISA Troponin T, Boehringer Mannheim Corp) in 51 consec
utively sampled patients from 1 day to 34 years of age (median=5.7 yea
rs) undergoing cardiovascular (n=19) or noncardiovascular (n=17) surge
ry or who received doxorubicin for acute lymphoblastic leukemia (ALL)
(n=15). Minimum detectable cTnT elevations were 0.03 ng/mL. cTnT was m
easurable in children of all ages with myocyte damage. In patients who
underwent cardiovascular surgery, a correlation was noted between a s
core of increasing surgical severity and the mean level of postoperati
ve cTnT (r =.79, P<.0001). Postoperative cTnT levels were elevated in
children who completed cardiovascular surgery with an open chest compa
red with those with a closed chest (P=.0083). In addition, cTnT levels
before cardiovascular surgery predicted postoperative survival (P=.00
7). cTnT elevations were observed after initial doxorubicin therapy fo
r ALL. The magnitude of elevation predicted left ventricular dilatatio
n (r=.80 when variables were treated as continuous, P=.003) and wall t
hinning (r =.61, P=.044) 9 months later. Conclusions Elevations of blo
od cTnT in children relate to the severity of myocardial damage and pr
edict subsequent subclinical and clinical cardiac morbidity and mortal
ity.